TY  - GEN
AU  - Palmer,Andrew J
AU  - Valentine,William J
AU  - Chen,Roland
AU  - Mehin,Nazanin
AU  - Gabriel,Sylvie
AU  - Bregman,Bruno
AU  - Rodby,Roger A
TI  - A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
SN  - 1460-2385
PY  - 2008///0501
KW  - Adult
KW  - Age Distribution
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Disease-Free Survival
KW  - Female
KW  - Health Care Costs
KW  - Humans
KW  - Hypertension
KW  - Hypoglycemic Agents
KW  - therapeutic use
KW  - Incidence
KW  - Kidney Failure, Chronic
KW  - Life Expectancy
KW  - trends
KW  - Male
KW  - Mass Screening
KW  - Middle Aged
KW  - Models, Economic
KW  - Morbidity
KW  - Prognosis
KW  - Quality of Life
KW  - Renal Insufficiency
KW  - drug therapy
KW  - Survival Rate
KW  - United States
KW  - epidemiology
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/ndt/gfn082
ER  -